Navigation Links
Medical Experts Call for Obama Administration, Congress to Boost Funding for Prostate Cancer Imaging Research
Date:1/14/2009

New Tools Would Transform Diagnostics, Treatment; Save Lives, Health Dollars

BETHESDA, Md., Jan. 14 /PRNewswire-USNewswire/ -- A group of more than 40 leaders of academia, industry, philanthropy and advocacy called today for the Obama Administration, Congress, the National Institutes of Health and the Department of Defense to increase federal funding for research into imaging technologies for less invasive and more accurate diagnosis of prostate cancer.

Meeting this week in Bethesda, Md, at a conference convened by the AdMeTech Foundation, the medical experts discussed strategies for speeding development of imaging technologies for prostate cancer modeled after life-saving mammograms for women. Advanced prostate imaging -- or a "man-o-gram" -- would save lives and an estimated $5 billion per year in health care costs.

"As physicians, scientists, educators and patients, we are personally concerned about the human and societal costs of prostate cancer. We firmly believe that more accurate imaging technology would lead to better patient care, including guidance for diagnosis, biopsy and minimally invasive therapy," today's consensus statement reads. "The AdMeTech Foundation conference clearly demonstrated that real and important improvements in prostate cancer care are at hand if we are resolved to increase the national investment in prostate diagnostics."

Conference participants also signed a letter to Dr. Raynard S. Kington, acting director of the National Institutes of Health, urging increased federal research funding for prostate cancer imaging diagnostics.

Today's calls for funding action adds professional weight to similar support in legislation considered in the 110th Congress (House Resolution 353), a recent letter to the Secretary of Health and Human Services and the Directors of the National Institutes of Health and National Cancer Institute by seven Senators, and t
'/>"/>

SOURCE AdMeTech Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award
2. Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center
3. Codapedia(TM) Announced, Wiki for Coding and Medical Reimbursement
4. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
5. AFB Survey Finds Drug Labeling Puts People with Vision Loss at Serious Medical Risk
6. Hospital diabetes care standards not met by US academic medical centers
7. Tulip Systems Launches New Division: Atlanta Medical Websites
8. Zassi Medical Evolutions Launches New Online Company That Uses Business DNA to Deliver Advanced Discovery, Collaboration, and Business Intelligence Tools to the Medical Device Industry
9. Houstons NuPhysicia LLC has Remote Medical Technologies and Services Featured on CNN Health Report
10. Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine
11. Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...wire/ -- Recent news reports have highlighted the ...hat physicians meet high standards in their chosen... of Medical Specialties (ABMS), which coordinates ...to develop and implement educational and professio... of physician specialists. Certification by an AB...
(Date:7/2/2009)...wire/ -- Pro-life forces won an important battle y...ld a state law regulating that abortion centers mu... RU-486 (also known as the "abortion pill") in ord... , , The ruling came in Rogers v. Planned Pare...04 law requiring that those administering RU-486 c...
(Date:7/2/2009)...honored in Washington, D.C. , , ARLINGTON, Tex...th Resources has received the Best Employers for ...ss Group on Health. , , (Logo: http://www.ne..., , The award recognizes the nation,s leading co...healthy workplace and for helping employees and th...
(Date:7/2/2009)... threat, expert says , , THURSDAY, July... certain species of wildlife, which need to be pro... , "Cancer is one of the leading health concern...of human deaths. But we now understand that cancer...hor Denise McAloose, chief pathologist for the Wil...
Breaking Medicine News(10 mins):Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Cancer Endangers Some Wildlife Species 2
... have discovered a naturally occurring hormone tha...%. Mice lacking the gene for klotho began showing ...e and die after // about two months when compared ...is has indeed opened up new avenues into improving...
... report published in the latest edition of The Lan...n treating adults with malaria than the common dru...r the treatment // of severe malaria throughout Af... But even with prompt administration of the drug i...
...ug 26 . Japanese encephalitis deaths continue to r...ed 220 in less than a month. // Dr.T.N.Dhole from...i Post Graduate Institute of Medical Sciences bla... spread of the killer brain fever, which had been ...
...n country of Uganda reports that all the efforts t...ing. The report on this topic was reported in this...nosoma brucei rhodesiense sleeping // sickness in ...lt of the movement of the livestock reservoir of t...
Other Medicine News:Health News:Encephalitis Deaths Cross 220 in Uttar Pradesh 2
(Date:6/29/2009)...Study Seeks to Assess RSV Burden in Outpatient Set...ment to Pediatric Research , , GAITHERSBURG, ...o advance its commitment to pediatric research wit...prospective study designed to assess the burden of...nfants 32-to-35 weeks gestational age (GA) in outp...
(Date:6/29/2009)...or abdominal surgery patients achieved primary and...June 29 AcelRx Pharmaceuticals, In...d Phase 2 clinical study evaluating the safety and...r the management of acute post-operative pain in p...ization. Compared to placebo, patients receiving A...
(Date:6/29/2009)...TON, England, June 29 Vantia Thera...oping novel, small molecule drugs,targeting large...results from,a Phase IIa clinical trial of its le...e trial showed that oral VA106483 was successful i...etic effect in patients, as determined by,increas...
(Date:6/28/2009)...E DO CORONADO, Portugal, June 29 D...at add-on treatment with the novel,once-daily an... ESL) resulted,in a marked and sustained decrease... Results from the one-year extension of a pivot...resented at the International Congress for Epileps...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 1Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 2Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 3HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 1HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 2HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 3BioMS Medicals relapsing remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 6610 1BioMS Medicals relapsing remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 6610 2Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 1Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 2Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 3Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 4
...IRE)--Mar 6, 2007 - POZEN Inc.,(NASDAQ: POZN), tod...n" PA 325 proof-of-concept study conducted during ...ormulation of 325mg of,aspirin surrounded by a 20m... proton pump inhibitor., The PA 325, 28 day study,...f 50. Each subject was treated with either once a ...
...LL, N.C., US, March 06, 2007,/PRNewswire/ -- AOP O...io, Inc. ("Lantibio") today announced positive fin...linded Phase II clinical,study of Moli1901, an exp.... Moli1901 is being developed by AOP Orphan in,Eur...ent with,Lantibio. The study, performed at multipl...
Other Medicine Technology:POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 2POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4
...n (MST) is a surgical technique designed to treat ...rea that cannot be surgically resected without cau... technique, fine parallel cuts are made in the cor... seizure discharge without compromising the vertic...
...s were developed to reproducibly and accurately cr... double bundle PCL reconstruction. The guides simp...teromedial femoral tunnel sockets drilled endoscop...erolateral tunnel placement a guide can be used ei...
...t offers surgeons an alternative to traditional ar...hammertoe deformity. The prosthesis is constructed...ed for the proximal interphalangeal joints of digi...atomic hinge design similar to that used in digita...
The primary objective of the BioPro Toe implant is to provide a durable arthroplasty that will relieve pain and restore motion while leaving the biomechanical arrangement of the foot undisturbed. The
Medicine Products: